Bryan Garnier - Pernod Ricard (UG) Beverages: Our Top Pick for Q1 2021: Pernod Ricard

Report

Bryan Garnier

Virginie Roumage

Beverages: Our Top Pick for Q1 2021: Pernod Ricard

BEVERAGES

Our Top Pick for Q1 2021: Pernod Ricard

Spirits: a satisfying performance in a challenging context
Pernod Ricard: our choice for the quarter to come:
Revising our full year forecasts upwards for the French company

12/01/2021 3 EN

Underlying

Pernod Ricard

See profile

Provider

Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

See profile

Analysts

Virginie Roumage

Other Reports on these Companies

Sabadell

PERNOD RICARD: VENTAS 3T’24 (ANÁLISIS BANCO SABADELL)

Rdos. 3T'24 vs 3T'23: Ventas: 2.347 M euros (-1,8% vs +2,8% consenso); Rdos. 9meses'24 vs 9meses'23: Ventas: 8.937 M euros (-6,0% vs -4,8% consenso).

EUR 100.00

April 25, 2024 April 25, 2024 1 ES

Sabadell

INFORME DIARIO 25 ABRIL + RDOS. ESPAÑA Y EUROPA 1T’24. IDEAS DESTACADAS Y PREVIEWS (ANÁLISIS BANCO SABADELL)

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACS, AEDAS, CELLNEX, EBRO FOODS, IBERDROLA. EUROPA: BASF, BNP, PERNOD RICARD, SANOFI, SCHNEIDER. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 1T’24 que se publicarán en España y Europa en los próximos días. Jornada de más a menos Las bolsas europeas comenzaron bien la jornada, pero fueron perdiendo fuelle hasta terminar con pérdidas tras la apertura a la baja de las bolsas en EE.UU. y un nuevo repunte d...

EUR 100.00

April 25, 2024 April 25, 2024 1 ES

Sabadell

PERNOD RICARD: MENSAJES DE LA CONFERENCE CALL RDOS. 1S’24 (ANÁLISIS BANCO SABADELL)

De la conference call de Rdos. 1S’24, destacamos los siguientes mensajes:  En EE.UU. continúa el proceso de normalización de inventarios, mientras que la demanda se mantiene muy resiliente.

EUR 50.00

February 15, 2024 February 15, 2024 1 ES

Onward: Model Update

We update our financial model after Onward medical released FY 2023 results last week The rating remains unchanged with a Buy recommendation and EUR 20 PT.

15h / 13m 15h / 13m 1 EN

Cedric Rossi

Cedric Rossi

Hugo Boss: Weak China and month of April spoilt the mood

In our view, the sharp negative market reaction was triggered by subdued trends in China and April trends which were slightly below the Q1 top-line performance (+6% FX-n), on top of another tough comparison base (Q2 2023: +20% FX-n). Whilst FY24 outlook was reiterated, management's relatively cauti

16h / 1m 16h / 1m 1 EN

Oscar Haffen Lamm

Oscar Haffen Lamm

Egetis reports Q1, on track with US trial

Egetis reported Q1 2024 results with an operating loss of SEK (68.6m) and a cash position of SEK 251.7m. In the pipeline, the most important update has been to the status of the critical US phase 3 trial, where the company reported that 13/16 patients have been recruited, whereof 6 patients have co

16h / 1m 16h / 1m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Beverages: Our Top Pick for Q1 2021: Pernod Ricard

PERNOD RICARD: VENTAS 3T’24 (ANÁLISIS BANCO SABADELL)

INFORME DIARIO 25 ABRIL + RDOS. ESPAÑA Y EUROPA 1T’24. IDEAS DESTACADAS Y PREVIEWS (ANÁLISIS BANCO SABADELL)

PERNOD RICARD: MENSAJES DE LA CONFERENCE CALL RDOS. 1S’24 (ANÁLISIS BANCO SABADELL)

Onward: Model Update

Hugo Boss: Weak China and month of April spoilt the mood

Egetis reports Q1, on track with US trial

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe